Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Basal Cell 6Carcinoma, Non-Small-Cell Lung 3Pancreatic Neoplasms 2Mycosis Fungoides 2Keratosis, Actinic 2Basal Cell Nevus Syndrome 2Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Stomatitis 1Squamous Cell Carcinoma of Head and Neck 1Skin Neoplasms 1Sezary Syndrome 1Salivary Gland Neoplasms 1Pleural Diseases 1Pain 1Non-Muscle Invasive Bladder Neoplasms 1Neoplasms 1Mesothelioma, Malignant 1Lymphoma, T-Cell, Cutaneous 1Esthesioneuroblastoma, Olfactory 1Cholangiocarcinoma 1Carcinoma, Transitional Cell 1Adenocarcinoma, Follicular 1Adenocarcinoma of Lung 1

Interventions

Mitomycin 11Gemcitabine 7BCG Vaccine 4Imiquimod 2Administration, Intravesical 2viscum album peptide 1pemigatinib 1pembrolizumab 1erdafitinib 1dodecyl maltoside 1Water 1VPM1002 recombinant BCG vaccine 1VB4-845 1Therapeutics 1Photochemotherapy 1Neoadjuvant Therapy 1Interferon-alpha 1Hyaluronic Acid 1High-Intensity Interval Training 1Gels 1Ethacrynic Acid 1Epirubicin 1Educational Status 1Doxorubicin 1Docetaxel 1Dihematoporphyrin Ether 1Cystoscopy 1Celecoxib 1BCG Connaught 15-aminolevulinic acid hexyl ester 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Non-Muscle Invasive Bladder Neoplasms × 1-phenyl-3,3-dimethyltriazene × Clear all
NCT03053635 2018-08-20

Intravesical Photodynamic Therapy (PDT) in BCG Refractory High-Risk Non-muscle Invasive Bladder Cancer (NMIBC) Patients

TheralaseĀ® Technologies Inc.

Phase 1 Completed
6 enrolled
Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚔